Longeveron Inc. (NASDAQ: LGVN)
$4.00
+0.4800 ( +13.64% ) 24.6M
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Market Data
Open
$4.00
Previous close
$3.52
Volume
24.6M
Market cap
$38.40M
Day range
$3.55 - $4.95
52 week range
$0.77 - $36.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | May 14, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |
8-k | 8K-related | 15 | May 10, 2024 |
4 | Insider transactions | 1 | May 06, 2024 |
4 | Insider transactions | 1 | May 06, 2024 |
8-k | 8K-related | 19 | Apr 18, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
8-k | 8K-related | 21 | Apr 11, 2024 |